n Cardiovascular Journal of South Africa - One great leap for lipid-lowering drugs : drug trends in cardiology




Extracted from text ... A far-reaching global clinical research programme, designed to build on the success of the statin class and contribute to the understanding of the role of statins in the management of cardiovascular risk reduction, was announced at the European Society of Cardiology, Berlin by AstraZeneca. The initiative known as the GALAXY Programme, One great leap for lipid-lowering drugs aims to include over 80 000 subjects in more than 30 countries around the world. It has been based on the principles suggested by previous and ongoing statin studies, that the best effects on lipids and atherosclerosis translate into the best reductions in ..


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error